Clinical Trials Browser

Phase 2 × OTHER_GOV × 90 days × Clear all

NCT05398861 2026-04-16

Utidelone Combined With Bevacizumab in the Treatment of ≥ 2 Lines of HER-2 Negative Advanced Breast Cancer

Phase 2 Recruiting

HER-2 Negative Breast Cancer

NCT03446547 2026-04-14

ASTEROID

Phase 2 Completed

Carcinoma, Non-Small-Cell Lung

NCT06388720 2026-04-13

IMGeS

Phase 2 Recruiting

Urinary Bladder Neoplasms

NCT04433156 2026-04-09

VR-CAP in the First-line Treatment for Patients With Marginal Zone Lymphoma

Phase 2 Completed

Lymphoma, B-Cell, Marginal Zone

NCT06708702 2026-04-09

Copaíba-based Mouthwash in Oral Mucotitis Prevention and Treatment in Oral Cancer Patients During Radioteraphy

Phase 2 Withdrawn

Stomatitis, Ulcer

NCT04660097 2026-04-08

Anlotinib Plus Durvalumab-Platinum-Etoposide in First-line Treatment Extensive Small-cell Lung Cancer

Phase 2 Completed

Small Cell Lung Carcinoma

NCT07514494 2026-04-07

PrimPIPAC

Phase 2 Recruiting

Peritoneal Neoplasms

NCT05394285 2026-04-06

A Clinical Study of Hetrombopag Olamine Tablets for Thrombocytopenia Induced by Anti-tumor Treatment in Advanced Breast Cancer

Phase 2 Completed

Breast Neoplasms

NCT05769010 2026-04-01

Study of SHR-A1811 in HER2-expression Advanced Breast Cancer With Brain Metastases

Phase 2 Recruiting

Breast Neoplasms

NCT07505849 2026-04-01

ZR2 Versus R2 Regimen in the Treatment of Newly Diagnosed Follicular Lymphoma

Phase 2 Not yet recruiting

Lymphoma, Follicular

NCT07256236 2026-03-30

SKB264 Plus QL1706 in Recurrent or Metastatic Cervical Cancer

Phase 2 Recruiting

Uterine Cervical Neoplasms

NCT05805631 2026-03-24

Intrathecal Pemetrexed for Leptomeningeal Metastasis in EGFR-Mutant NSCLC

Phase 2 Recruiting

Carcinoma, Non-Small-Cell Lung, Meningeal Carcinomatosis

NCT07470840 2026-03-24

SBRT Plus Anlotinib and Bimepolizumab in Locally Advanced or Metastatic Renal Cell Carcinoma

Phase 2 Not yet recruiting

Carcinoma, Renal Cell

NCT07469306 2026-03-13

Short-Course RT Plus CAPOX and Tislelizumab vs Long-Course CRT Plus Tislelizumab for Locally Advanced Rectal Cancer

Phase 2 Not yet recruiting

Gastrointestinal

Locally Advanced Rectal Cancer

NCT06787183 2026-03-03

SCRT(Short Course Radiotherapy) Combined With CAPOX Plus QL1706 for Rectal Cancer Liver Metastases

Phase 2 Recruiting

Gastrointestinal

Locally Advanced Rectal Cancer With Liver Metastases

NCT07416253 2026-02-18

Trastuzumab Rezetecan vs Trastuzumab Deruxtecan in the Neoadjuvant Treatment of HER2 Positive Breast Cancer

Phase 2 Not yet recruiting

Breast Neoplasms

NCT07404176 2026-02-11

TENET

Phase 2 Recruiting

Neoplasms, Neuroendocrine Tumors

NCT06370416 2026-01-28

the Prevention of Bone Marrow Suppression Caused by Chemotherapy in Advanced NSCLC With Trilaciclib

Phase 2 Enrolling by invitation

Carcinoma, Non-Small-Cell Lung

NCT05036434 2026-01-23

ACCOMPLISH

Phase 2 Active not recruiting

Adrenocortical Carcinoma

NCT07363512 2026-01-23

Efficacy and Safety of Radiotherapy Combined With Tislelizumab and Anlotinib in the Treatment of Hepatocellular Carcinoma Complicated With Portal Vein Tumor Thrombus

Phase 2 Not yet recruiting

Gastrointestinal

Carcinoma, Hepatocellular

NCT07349303 2026-01-21

NEOPRIME

Phase 2 Recruiting

Melanoma